February 2012 Issue
Out-of-trend results from APRs offer unique insights into ingredients and finished products.
Modern control is the best way to ensure patient safety (and corporate survival).
Twitter's impact on the scientific community and scientific literature citations in particular is growing at a rapid rate.
"OUS" companies are enjoying the U.S. market, and creating a few jobs along the way.
CRBs Eric Unrau talks about what worked at Shire Lexington, and what limitations need to be overcome for single-use systems.
Until we can examine every supplier of excipient and API, well need to do our own detective work, but that will help us with Quality by Design.
When it comes to patient safety, says Brian Johnson, there should be no competitive advantage.